ID   PLCB1_HUMAN             Reviewed;        1216 AA.
AC   Q9NQ66; D3DW12; D3DW13; O60325; Q17RQ6; Q5TFF7; Q5TGC9; Q8IV93;
AC   Q9BQW2; Q9H4H2; Q9H8H5; Q9NQ65; Q9NQH9; Q9NTH4; Q9UJP6; Q9UM26;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1;
DE            EC=3.1.4.11;
DE   AltName: Full=PLC-154;
DE   AltName: Full=Phosphoinositide phospholipase C-beta-1;
DE   AltName: Full=Phospholipase C-I;
DE            Short=PLC-I;
DE   AltName: Full=Phospholipase C-beta-1;
DE            Short=PLC-beta-1;
GN   Name=PLCB1; Synonyms=KIAA0581;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RC   TISSUE=Brain;
RX   PubMed=11118617; DOI=10.1016/S0167-4781(00)00260-8;
RA   Caricasole A., Sala C., Roncarati R., Formenti E., Terstappen G.C.;
RT   "Cloning and characterization of the human phosphoinositide-specific
RT   phospholipase C-beta 1 (PLCbeta1).";
RL   Biochim. Biophys. Acta 1517:63-72(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=10760467; DOI=10.1016/S1388-1981(00)00012-3;
RA   Peruzzi D., Calabrese G., Faenza I., Manzoli L., Matteucci A.,
RA   Gianfrancesco F., Billi A.M., Stuppia L., Palka G., Cocco L.;
RT   "Identification and chromosomal localisation by fluorescence in situ
RT   hybridisation of human gene of phosphoinositide-specific phospholipase
RT   C beta 1.";
RL   Biochim. Biophys. Acta 1484:175-182(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 261-1216 (ISOFORM B).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 417-1062 (ISOFORMS A AND B).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   INTERACTION WITH DGKQ.
RX   PubMed=12799190; DOI=10.1016/S0014-4827(03)00115-0;
RA   Tabellini G., Bortul R., Santi S., Riccio M., Baldini G.,
RA   Cappellini A., Billi A.M., Berezney R., Ruggeri A., Cocco L.,
RA   Martelli A.M.;
RT   "Diacylglycerol kinase-theta is localized in the speckle domains of
RT   the nucleus.";
RL   Exp. Cell Res. 287:143-154(2003).
RN   [11]
RP   INVOLVEMENT IN EIEE12.
RX   PubMed=20833646; DOI=10.1093/brain/awq238;
RA   Kurian M.A., Meyer E., Vassallo G., Morgan N.V., Prakash N., Pasha S.,
RA   Hai N.A., Shuib S., Rahman F., Wassmer E., Cross J.H.,
RA   O'Callaghan F.J., Osborne J.P., Scheffer I.E., Gissen P., Maher E.R.;
RT   "Phospholipase C beta 1 deficiency is associated with early-onset
RT   epileptic encephalopathy.";
RL   Brain 133:2964-2970(2010).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-907.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by activated phosphatidylinositol-specific phospholipase
CC       C enzymes.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- SUBUNIT: Interacts with DGKQ. {ECO:0000269|PubMed:12799190}.
CC   -!- INTERACTION:
CC       Q8TAP6:CEP76; NbExp=3; IntAct=EBI-3396023, EBI-742887;
CC       Q13363-2:CTBP1; NbExp=3; IntAct=EBI-3396023, EBI-10171858;
CC       P56545:CTBP2; NbExp=3; IntAct=EBI-3396023, EBI-741533;
CC       Q8IY44:CTBP2; NbExp=3; IntAct=EBI-3396023, EBI-10171902;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-3396023, EBI-717422;
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Note=Colocalizes with the adrenergic receptors,
CC       ADREN1A and ADREN1B, at the nuclear membrane of cardiac myocytes.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=Q9NQ66-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9NQ66-2; Sequence=VSP_004718;
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 12 (EIEE12)
CC       [MIM:613722]: A form of epilepsy characterized by frequent tonic
CC       seizures or spasms beginning in infancy with a specific EEG
CC       finding of suppression-burst patterns, characterized by high-
CC       voltage bursts alternating with almost flat suppression phases.
CC       Patients may progress to West syndrome, which is characterized by
CC       tonic spasms with clustering, arrest of psychomotor development,
CC       and hypsarrhythmia on EEG. {ECO:0000269|PubMed:20833646}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: The receptor-mediated activation of PLC-beta-1 is
CC       mediated by two G-protein alpha subunits, alpha-Q and alpha-11.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25507.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB14641.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLCB1ID41742ch20p12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ278313; CAB98142.1; -; mRNA.
DR   EMBL; AJ278314; CAB98143.1; -; mRNA.
DR   EMBL; AY004175; AAF86613.1; -; mRNA.
DR   EMBL; AB011153; BAA25507.3; ALT_INIT; mRNA.
DR   EMBL; AL031683; CAI43121.1; -; Genomic_DNA.
DR   EMBL; AL034551; CAI43121.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI43121.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI43121.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI43121.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI43121.1; JOINED; Genomic_DNA.
DR   EMBL; AL031683; CAI43122.1; -; Genomic_DNA.
DR   EMBL; AL034551; CAI43122.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI43122.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI43122.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI43122.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI21973.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI21973.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI21973.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI21973.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI21973.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI21973.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI21974.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI21974.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI21974.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI21974.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI21974.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI22175.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI22175.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI22175.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI22175.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI22175.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI22175.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI43151.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI43151.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI43151.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI43151.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI43151.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI43151.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI43152.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI43152.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI43152.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI43152.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI43152.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI42238.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI42238.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI42238.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI42238.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI42238.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI42238.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI42239.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI42239.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI42239.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI42239.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI42239.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI22830.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI22830.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI22830.1; JOINED; Genomic_DNA.
DR   EMBL; AL049593; CAI22830.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI22830.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI22830.1; JOINED; Genomic_DNA.
DR   EMBL; AL050323; CAI22831.1; -; Genomic_DNA.
DR   EMBL; AL031683; CAI22831.1; JOINED; Genomic_DNA.
DR   EMBL; AL034551; CAI22831.1; JOINED; Genomic_DNA.
DR   EMBL; AL050315; CAI22831.1; JOINED; Genomic_DNA.
DR   EMBL; AL049632; CAI22831.1; JOINED; Genomic_DNA.
DR   EMBL; CH471133; EAX10372.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10373.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10374.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10376.1; -; Genomic_DNA.
DR   EMBL; BC069420; AAH69420.1; -; mRNA.
DR   EMBL; BC117231; AAI17232.1; -; mRNA.
DR   EMBL; AL137267; CAB70666.1; -; mRNA.
DR   EMBL; AK023689; BAB14641.1; ALT_INIT; mRNA.
DR   CCDS; CCDS13102.1; -. [Q9NQ66-1]
DR   CCDS; CCDS13103.1; -. [Q9NQ66-2]
DR   RefSeq; NP_056007.1; NM_015192.3. [Q9NQ66-1]
DR   RefSeq; NP_877398.1; NM_182734.2. [Q9NQ66-2]
DR   UniGene; Hs.431173; -.
DR   ProteinModelPortal; Q9NQ66; -.
DR   SMR; Q9NQ66; -.
DR   BioGrid; 116841; 16.
DR   IntAct; Q9NQ66; 6.
DR   MINT; MINT-5005654; -.
DR   STRING; 9606.ENSP00000338185; -.
DR   BindingDB; Q9NQ66; -.
DR   ChEMBL; CHEMBL4034; -.
DR   iPTMnet; Q9NQ66; -.
DR   PhosphoSitePlus; Q9NQ66; -.
DR   SwissPalm; Q9NQ66; -.
DR   DMDM; 12643814; -.
DR   EPD; Q9NQ66; -.
DR   MaxQB; Q9NQ66; -.
DR   PaxDb; Q9NQ66; -.
DR   PeptideAtlas; Q9NQ66; -.
DR   PRIDE; Q9NQ66; -.
DR   Ensembl; ENST00000338037; ENSP00000338185; ENSG00000182621. [Q9NQ66-1]
DR   Ensembl; ENST00000378637; ENSP00000367904; ENSG00000182621. [Q9NQ66-2]
DR   Ensembl; ENST00000378641; ENSP00000367908; ENSG00000182621. [Q9NQ66-2]
DR   GeneID; 23236; -.
DR   KEGG; hsa:23236; -.
DR   UCSC; uc002wna.5; human. [Q9NQ66-1]
DR   CTD; 23236; -.
DR   DisGeNET; 23236; -.
DR   GeneCards; PLCB1; -.
DR   HGNC; HGNC:15917; PLCB1.
DR   HPA; CAB004275; -.
DR   HPA; CAB005334; -.
DR   HPA; HPA034743; -.
DR   HPA; HPA057910; -.
DR   MalaCards; PLCB1; -.
DR   MIM; 607120; gene.
DR   MIM; 613722; phenotype.
DR   neXtProt; NX_Q9NQ66; -.
DR   OpenTargets; ENSG00000182621; -.
DR   Orphanet; 293181; Malignant migrating partial seizures of infancy.
DR   Orphanet; 3451; West syndrome.
DR   PharmGKB; PA33384; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOVERGEN; HBG053609; -.
DR   InParanoid; Q9NQ66; -.
DR   KO; K05858; -.
DR   OMA; MMDFINL; -.
DR   OrthoDB; EOG091G00XL; -.
DR   PhylomeDB; Q9NQ66; -.
DR   TreeFam; TF313216; -.
DR   BRENDA; 3.1.4.11; 2681.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-HSA-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418217; G beta:gamma signalling through PLC beta.
DR   Reactome; R-HSA-434316; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion.
DR   Reactome; R-HSA-500657; Presynaptic function of Kainate receptors.
DR   SignaLink; Q9NQ66; -.
DR   SIGNOR; Q9NQ66; -.
DR   ChiTaRS; PLCB1; human.
DR   GeneWiki; PLCB1; -.
DR   GenomeRNAi; 23236; -.
DR   PRO; PR:Q9NQ66; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000182621; -.
DR   ExpressionAtlas; Q9NQ66; baseline and differential.
DR   Genevisible; Q9NQ66; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; ISS:BHF-UCL.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IPI:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:BHF-UCL.
DR   GO; GO:0005521; F:lamin binding; IEA:Ensembl.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; ISS:AgBase.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0060466; P:activation of meiosis involved in egg activation; ISS:BHF-UCL.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:BHF-UCL.
DR   GO; GO:0045444; P:fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:BHF-UCL.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0007613; P:memory; ISS:BHF-UCL.
DR   GO; GO:2000438; P:negative regulation of monocyte extravasation; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISS:BHF-UCL.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; ISS:BHF-UCL.
DR   GO; GO:2000560; P:positive regulation of CD24 biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0048639; P:positive regulation of developmental growth; ISS:BHF-UCL.
DR   GO; GO:0040019; P:positive regulation of embryonic development; ISS:BHF-UCL.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; ISS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL.
DR   GO; GO:0080154; P:regulation of fertilization; ISS:BHF-UCL.
DR   GO; GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016280; PLC-beta.
DR   InterPro; IPR028400; PLC-beta1.
DR   InterPro; IPR014815; PLC-beta_C.
DR   InterPro; IPR009535; PLC-beta_CS.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF108; PTHR10336:SF108; 1.
DR   Pfam; PF06631; DUF1154; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   Pfam; PF08703; PLC-beta_C; 1.
DR   PIRSF; PIRSF000956; PLC-beta; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Cytoplasm; Epilepsy;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Membrane; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transducer.
FT   CHAIN         1   1216       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase beta-1.
FT                                /FTId=PRO_0000088486.
FT   DOMAIN      316    467       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      540    656       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      663    761       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   ACT_SITE    331    331       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    378    378       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     417    417       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     509    509       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     511    511       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     582    582       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     887    887       Phosphoserine; by PKC. {ECO:0000250}.
FT   MOD_RES     978    978       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES     987    987       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES    1199   1199       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   MOD_RES    1200   1200       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1B3}.
FT   VAR_SEQ    1142   1216       LQVELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSA
FT                                PLSLSSDPGKVNHKTPSSEELGGDIPGKEFDTPL -> GEG
FT                                SSSFLSETCHEDPSVSPNFTPPNPQALKW (in isoform
FT                                B). {ECO:0000303|PubMed:11118617,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_004718.
FT   VARIANT     854    854       E -> K (in dbSNP:rs2076413).
FT                                /FTId=VAR_050541.
FT   VARIANT     907    907       A -> P (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036547.
FT   CONFLICT      1     34       MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDD -> MGS
FT                                LQGIATKILIRILSDALIRKETDLKS (in Ref. 2;
FT                                AAF86613). {ECO:0000305}.
FT   CONFLICT    189    189       L -> M (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       P -> L (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       L -> F (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       P -> L (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    266    266       L -> P (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       P -> T (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    320    320       Q -> R (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    352    352       V -> A (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    366    366       K -> R (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    393    393       E -> K (in Ref. 2; AAF86613).
FT                                {ECO:0000305}.
FT   CONFLICT    983    983       P -> S (in Ref. 1; CAB98143).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1216 AA;  138567 MW;  6F4263D1A50C6FD1 CRC64;
     MAGAQPGVHA LQLKPVCVSD SLKKGTKFVK WDDDSTIVTP IILRTDPQGF FFYWTDQNKE
     TELLDLSLVK DARCGRHAKA PKDPKLRELL DVGNIGRLEQ RMITVVYGPD LVNISHLNLV
     AFQEEVAKEW TNEVFSLATN LLAQNMSRDA FLEKAYTKLK LQVTPEGRIP LKNIYRLFSA
     DRKRVETALE ACSLPSSRND SIPQEDFTPE VYRVFLNNLC PRPEIDNIFS EFGAKSKPYL
     TVDQMMDFIN LKQRDPRLNE ILYPPLKQEQ VQVLIEKYEP NNSLARKGQI SVDGFMRYLS
     GEENGVVSPE KLDLNEDMSQ PLSHYFINSS HNTYLTAGQL AGNSSVEMYR QVLLSGCRCV
     ELDCWKGRTA EEEPVITHGF TMTTEISFKE VIEAIAECAF KTSPFPILLS FENHVDSPKQ
     QAKMAEYCRL IFGDALLMEP LEKYPLESGV PLPSPMDLMY KILVKNKKKS HKSSEGSGKK
     KLSEQASNTY SDSSSMFEPS SPGAGEADTE SDDDDDDDDC KKSSMDEGTA GSEAMATEEM
     SNLVNYIQPV KFESFEISKK RNKSFEMSSF VETKGLEQLT KSPVEFVEYN KMQLSRIYPK
     GTRVDSSNYM PQLFWNAGCQ MVALNFQTMD LAMQINMGMY EYNGKSGYRL KPEFMRRPDK
     HFDPFTEGIV DGIVANTLSV KIISGQFLSD KKVGTYVEVD MFGLPVDTRR KAFKTKTSQG
     NAVNPVWEEE PIVFKKVVLP TLACLRIAVY EEGGKFIGHR ILPVQAIRPG YHYICLRNER
     NQPLTLPAVF VYIEVKDYVP DTYADVIEAL SNPIRYVNLM EQRAKQLAAL TLEDEEEVKK
     EADPGETPSE APSEARTTPA ENGVNHTTTL TPKPPSQALH SQPAPGSVKA PAKTEDLIQS
     VLTEVEAQTI EELKQQKSFV KLQKKHYKEM KDLVKRHHKK TTDLIKEHTT KYNEIQNDYL
     RRRAALEKSA KKDSKKKSEP SSPDHGSSTI EQDLAALDAE MTQKLIDLKD KQQQQLLNLR
     QEQYYSEKYQ KREHIKLLIQ KLTDVAEECQ NNQLKKLKEI CEKEKKELKK KMDKKRQEKI
     TEAKSKDKSQ MEEEKTEMIR SYIQEVVQYI KRLEEAQSKR QEKLVEKHKE IRQQILDEKP
     KLQVELEQEY QDKFKRLPLE ILEFVQEAMK GKISEDSNHG SAPLSLSSDP GKVNHKTPSS
     EELGGDIPGK EFDTPL
//
